S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
MXCT · MaxCyte, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
MaxCyte Inc (MXCT)
NASDAQ NMS - GLOBAL MARKET
Life Sciences Tools & Services
$1.47
+0.04
(+2.80%)
● At close: October 21 at 4:00:00 PM EDT
$1.47
+0.00
(+0.00%)
Overnight:
9:58:37 PM EDT
DAY'S RANGE
$1.47
$1.41
$1.52
52-WEEK RANGE
$1.47
$0.64
$1.80
What's happening
- MXCT is up 2.80% today, trading at $1.47. — Live quote
- Volume today (106,328) is well below its 3-month average of 1,041,090. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.08 actual vs. $-0.09 estimated (+12.9%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 5
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (12 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
MXCT
-7.74%
vs S&P 500
-20.52%
1-YEAR RETURN
MXCT
-18.29%
vs S&P 500
-32.85%
6-MONTH RETURN
MXCT
+75.46%
3-MONTH RETURN
MXCT
+16.26%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.08
Est. $-0.09
BEAT +12.9%
2026-04-26 (Q1 2026)
$-0.04
Est. $-0.08
BEAT +51.0%
2026-01-26 (Q4 2025)
$-0.06
Est. $-0.08
BEAT +26.5%
2025-10-26 (Q3 2025)
$-0.09
Est. $-0.11
BEAT +19.8%
Valuation Measures & Ratios
Enterprise Value4$121.7M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)4.40
Price / Book70.83
EV4 / Revenue3.92
EV4 / EBITDA—
Profit Margin-114.77%
Operating Margin-134.59%
Return on Equity (ROE8)-21.01%
Return on Assets (ROA9)-17.93%
Avg Volume (3M)1,041,090
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $137.0M | $83.6M | $164.5M | $224.5M | $281.2M |
| P/E | -3.57 | -2.10 | -3.53 | -5.15 | -6.90 |
| Price/Sales | 4.25 | 2.36 | 4.85 | 5.99 | 6.97 |
| Price/Book | 0.86 | 0.50 | 0.91 | 1.18 | 1.41 |
| EV/Revenue | 3.78 | 1.95 | 4.47 | 5.58 | 6.39 |
| EV/EBITDA | -3.00 | -1.62 | -3.01 | — | — |
| ROE | -24.19% | -23.70% | -25.84% | -22.83% | -20.42% |
| ROA | -20.79% | -20.46% | -21.82% | -19.82% | -17.71% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short1,089,972
Change from Prior Settlement-6.87%
% of Float—
Days to Cover (Short Ratio)3.14
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-10-14; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -14.5% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -114.8%. Finnhub fundamentals ↗
- Trailing 52-week price return is -18.3%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on MXCT
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.3M | $9.7M | $6.8M | $8.5M | $10.4M | $8.2M | $10.4M | $11.3M |
| Gross profit | $5.6M | $8.1M | $5.2M | $7.0M | $8.9M | $6.2M | $8.9M | $9.9M |
| Operating income | -$10.2M | -$6.2M | -$14.1M | -$14.2M | -$12.3M | -$14.1M | -$12.0M | -$12.3M |
| Net income | -$8.9M | -$4.8M | -$12.4M | -$12.4M | -$10.3M | -$11.6M | -$9.4M | -$9.5M |
| EPS (diluted) | $-0.08 | $-0.04 | $-0.12 | $-0.12 | $-0.10 | $-0.11 | $-0.09 | — |
| EPS (basic) | $-0.08 | $-0.04 | $-0.12 | $-0.12 | $-0.10 | $-0.11 | $-0.09 | $-0.09 |
| Operating margin | -$141 | -$64 | -$207 | -$167 | -$118 | -$172 | -$115 | -$108 |
| Net margin | -$122 | -$49 | -$182 | -$145 | -$99 | -$142 | -$90 | -$84 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $184.7M | $194.5M | $202.5M | $213.5M | $219.8M | $230.0M | $239.5M | $248.6M |
| Total liabilities | $25.9M | $26.6M | $31.0M | $33.2M | $29.0M | $30.5M | $33.2M | $35.3M |
| Stockholders' equity | $158.8M | $167.9M | $171.5M | $180.3M | $190.7M | $199.4M | $206.3M | $213.3M |
| Total current assets | $121.3M | $122.9M | $118.4M | $124.6M | $143.2M | $155.7M | $171.7M | $172.9M |
| Total current liabilities | $9.9M | $10.2M | $14.3M | $16.1M | $11.6M | $12.7M | $15.8M | $17.6M |
| Cash & equivalents | $15.0M | $14.6M | $20.1M | $13.0M | $15.2M | $23.4M | $27.9M | $37.0M |
| Marketable securities (current) | $90.6M | $92.3M | $83.0M | $92.8M | $111.3M | $114.9M | $126.6M | $116.9M |
| Accounts receivable | $3.9M | $4.2M | $3.5M | $8.3M | $5.8M | $5.5M | $4.7M | $4.6M |
| Inventory | $7.8M | $7.6M | $7.5M | $7.6M | $7.9M | $8.3M | $8.9M | $10.4M |
| Other current assets | — | — | — | — | — | — | — | — |
| Marketable securities (non-current) | $36.2M | $40.8M | $52.6M | $52.3M | $38.6M | $36.4M | $35.8M | $42.8M |
| Property, plant & equipment | $14.9M | $16.6M | $17.5M | $18.6M | $19.4M | $19.9M | $19.7M | $21.0M |
| Goodwill | — | — | — | $3.6M | $3.7M | $3.9M | — | — |
| Intangible assets | $766.0K | $783.0K | $650.0K | $667.0K | $638.0K | $498.0K | — | — |
| Other non-current assets | $1.0M | $2.6M | $2.5M | $2.6M | $2.8M | $1.9M | $1.5M | $1.1M |
| Accounts payable | $1.7M | $1.2M | $1.4M | $1.3M | $1.2M | $2.3M | $1.4M | $1.9M |
| Deferred revenue (current) | $2.5M | $3.3M | $3.6M | $5.2M | $2.6M | $4.1M | $5.3M | $6.7M |
| Other non-current liabilities | $302.0K | $262.0K | $263.0K | $227.0K | $248.0K | $270.0K | $274.0K | $277.0K |
| Common stock & paid-in capital | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M |
| Retained earnings | -$275.1M | -$266.2M | -$261.5M | -$251.9M | -$239.5M | -$227.1M | -$216.9M | -$206.3M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.7M | -$8.2M | -$2.7M | -$7.5M | -$9.9M | -$14.4M | -$7.8M | -$4.4M |
| Investing cash flow | $6.6M | $2.7M | $9.7M | $5.2M | $1.5M | $9.5M | -$1.7M | $3.6M |
| Financing cash flow | -$1.4M | $5.0K | $105.0K | $14.0K | $154.0K | $383.0K | $412.0K | $228.0K |
| Free cash flow | -$4.7M | -$8.2M | -$2.9M | -$7.8M | -$10.4M | -$15.1M | -$8.0M | -$4.8M |
| Capital expenditures | $62.0K | $72.0K | $231.0K | $300.0K | $584.0K | $653.0K | $147.0K | $406.0K |
| Depreciation & amortization | $978.0K | $1.0M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M |
| Share-based compensation | $1.2M | $1.1M | $706.0K | $2.0M | $3.5M | $3.0M | $3.1M | $3.4M |
| Change in accounts receivable | -$324.0K | $743.0K | -$4.8M | $2.6M | $238.0K | $839.0K | $122.0K | -$21.0K |
| Change in inventory | $472.0K | $380.0K | $72.0K | $107.0K | -$223.0K | -$531.0K | -$527.0K | -$2.0K |
| Purchases of investments | $11.4M | $25.1M | $28.3M | $34.5M | $28.9M | $34.6M | $32.5M | $39.0M |
| Share repurchases | $1.5M | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $33.0M | $38.6M | $41.3M | $44.3M | $33.9M |
| Gross profit | $26.8M | $31.5M | $36.5M | $39.2M | $30.2M |
| Operating income | -$51.9M | -$51.2M | -$48.3M | -$27.4M | -$18.2M |
| Net income | -$44.6M | -$41.1M | -$37.9M | -$23.6M | -$19.1M |
| EPS (diluted) | $-0.42 | $-0.39 | $-0.37 | $-0.23 | $-0.21 |
| EPS (basic) | $-0.42 | $-0.39 | $-0.37 | $-0.23 | $-0.21 |
| Operating margin | -$157 | -$133 | -$117 | -$62 | -$54 |
| Net margin | -$135 | -$106 | -$92 | -$53 | -$56 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $202.5M | $239.5M | $268.3M | $286.7M | $284.1M |
| Total liabilities | $31.0M | $33.2M | $36.1M | $32.7M | $21.2M |
| Stockholders' equity | $171.5M | $206.3M | $232.2M | $254.0M | $262.9M |
| Total current assets | $118.4M | $171.7M | $190.2M | $252.3M | $270.4M |
| Total current liabilities | $14.3M | $15.8M | $17.9M | $15.4M | $15.6M |
| Cash & equivalents | $20.1M | $27.9M | $46.5M | $11.1M | $47.8M |
| Marketable securities (current) | $83.0M | $126.6M | $121.8M | $216.3M | $207.3M |
| Accounts receivable | $3.5M | $4.7M | $5.8M | $11.2M | $6.9M |
| Inventory | $7.5M | $8.9M | $12.2M | $8.6M | $5.2M |
| Marketable securities (non-current) | $52.6M | $35.8M | $42.9M | — | — |
| Property, plant & equipment | $17.5M | $19.7M | $23.5M | $23.7M | $7.7M |
| Intangible assets | $650.0K | — | — | — | — |
| Other non-current assets | $2.5M | $1.5M | $388.0K | $809.0K | $316.7K |
| Accounts payable | $1.4M | $1.4M | $743.0K | $292.0K | $1.8M |
| Deferred revenue (current) | $3.6M | $5.3M | $5.1M | $6.7M | $6.7M |
| Other non-current liabilities | $263.0K | $274.0K | $283.0K | $1.3M | $450.2K |
| Common stock & paid-in capital | $1.1M | $1.1M | $1.0M | $1.0M | $1.0M |
| Retained earnings | -$261.5M | -$216.9M | -$175.8M | -$137.9M | -$114.3M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$34.4M | -$27.6M | -$21.7M | -$14.8M | -$10.7M |
| Investing cash flow | $25.9M | $6.9M | $55.0M | -$24.8M | -$195.0M |
| Financing cash flow | $656.0K | $2.1M | $2.1M | $2.9M | $234.7M |
| Free cash flow | -$36.2M | -$29.3M | -$25.4M | -$33.3M | -$14.5M |
| Capital expenditures | $1.8M | $1.7M | $3.7M | $18.5M | $3.8M |
| Depreciation & amortization | $4.3M | $4.3M | $4.2M | $2.7M | $1.4M |
| Share-based compensation | $9.2M | $13.1M | $14.0M | $11.8M | $8.0M |
| Change in accounts receivable | -$1.1M | -$1.2M | -$5.2M | $4.6M | $1.7M |
| Change in inventory | -$575.0K | -$1.4M | $4.5M | $3.5M | $1.4M |
| Purchases of investments | $126.3M | $150.9M | $255.1M | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding MXCT as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-06-18 to 2026-06-17
Recent transactions
- Most recent: Johnston John Joseph (Reporting person) — Grant / award of 30,421 shares on 2026-06-17.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Johnston John Joseph | Reporting person | Grant / award | 2026-06-17 | 30,421 |
| Hemrajani Rekha | Reporting person | Grant / award | 2026-06-17 | 30,421 |
| Erck Stanley C | Reporting person | Grant / award | 2026-06-17 | 30,421 |
| DOUGLAS RICHARD | Reporting person | Grant / award | 2026-06-17 | 30,421 |
| Collins Cynthia | Reporting person | Grant / award | 2026-06-17 | 30,421 |
| Brooke William W | Reporting person | Grant / award | 2026-06-17 | 30,421 |
| BALTHROP PATRICK J | Reporting person | Grant / award | 2026-06-17 | 30,421 |
| Al-Wakeel Yasir B. | Reporting person | Grant / award | 2026-06-17 | 30,421 |
| Ahuja Parmeet | Chief Financial Officer | Grant / award | 2026-04-15 | 187,500 |
| Masoud Maher | President and CEO | Grant / award | 2026-03-27 | 300,000 |
| Swirsky Douglas J | CHIEF FINANCIAL OFFICER | Open market sale | 2026-03-17 | 10,142 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-06-17 | Johnston John Joseph | Reporting person | Grant / award | 30,421 | $0.00 |
| 2026-06-17 | Hemrajani Rekha | Reporting person | Grant / award | 30,421 | $0.00 |
| 2026-06-17 | Erck Stanley C | Reporting person | Grant / award | 30,421 | $0.00 |
| 2026-06-17 | DOUGLAS RICHARD | Reporting person | Grant / award | 30,421 | $0.00 |
| 2026-06-17 | Collins Cynthia | Reporting person | Grant / award | 30,421 | $0.00 |
| 2026-06-17 | Brooke William W | Reporting person | Grant / award | 30,421 | $0.00 |
| 2026-06-17 | BALTHROP PATRICK J | Reporting person | Grant / award | 30,421 | $0.00 |
| 2026-06-17 | Al-Wakeel Yasir B. | Reporting person | Grant / award | 30,421 | $0.00 |
| 2026-04-15 | Ahuja Parmeet | Chief Financial Officer | Grant / award | 187,500 | $0.00 |
| 2026-03-27 | Masoud Maher | President and CEO | Grant / award | 300,000 | $0.00 |
| 2026-03-17 | Swirsky Douglas J | CHIEF FINANCIAL OFFICER | Open market sale | 10,142 | $0.81 |
| 2025-08-13 | Swirsky Douglas J | CHIEF FINANCIAL OFFICER | Open market purchase | 50,000 | $1.29 |
| 2025-08-13 | Masoud Maher | President and CEO | Open market purchase | 75,000 | $1.37 |
| 2025-08-13 | Erck Stanley C | Reporting person | Open market purchase | 100,000 | $1.37 |
| 2025-08-13 | DOUGLAS RICHARD | Reporting person | Open market purchase | 80,000 | $1.39 |
| 2025-08-13 | Brooke William W | Reporting person | Open market purchase | 50,000 | $1.29 |
| 2025-06-25 | Hemrajani Rekha | Reporting person | Open market sale | 10,684 | $2.09 |
| 2025-06-18 | Johnston John Joseph | Reporting person | Grant / award | 29,210 | $0.00 |
| 2025-06-18 | Hemrajani Rekha | Reporting person | Grant / award | 29,210 | $0.00 |
| 2025-06-18 | Erck Stanley C | Reporting person | Grant / award | 29,210 | $0.00 |
| 2025-06-18 | DOUGLAS RICHARD | Reporting person | Grant / award | 29,210 | $0.00 |
| 2025-06-18 | Collins Cynthia | Reporting person | Grant / award | 29,210 | $0.00 |
| 2025-06-18 | Brooke William W | Reporting person | Grant / award | 29,210 | $0.00 |
| 2025-06-18 | BALTHROP PATRICK J | Reporting person | Grant / award | 29,210 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:39 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-14 | 8-K | 2026-10-14 | View on SEC.gov → |
| 2026-08-13 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-12 | 8-K | 2026-08-12 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-17 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-17 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-17 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-17 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-17 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-17 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-17 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-17 | View on SEC.gov → |
| 2026-06-17 | 8-K | 2026-06-17 | View on SEC.gov → |
Recent news
Headlines about MXCT (MaxCyte, Inc.). Links open the publisher — we don’t host full articles.
-
MaxCyte consensus sets USD 6.00 target for MaxCyte stock
AD HOC NEWS · 2026-10-20 -
MaxCyte(MXCT) Stock Options Chain | Quotes & News
Moomoo · 2026-10-20 -
MXCT261016C00001000 Interactive Stock Chart | MXCT Oct 2026 1.000 call Stock
Yahoo Finance · 2026-10-19 -
MaxCyte stock has November 10, 2026 earnings date - ad-hoc-news.de
ad-hoc-news.de · 2026-10-17 -
November 10, 2026 results are next for MaxCyte stock - ad-hoc-news.de
ad-hoc-news.de · 2026-10-15 -
These stocks have an unusual volume in today's session
ChartMill · 2026-10-15 -
Liontrust Investment Partners Discloses Investment at MaxCyte with 5.03% Stake
TradingView · 2026-10-15 -
An investor reports over 5% of MaxCyte (MXCT) after October 14 share purchases.
Stock Titan · 2026-10-15
No headlines in this category right now — try “All”.